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Engagement with care for those living with HIV is aimed at establishing a strong relationship between patients and their health
care provider and is often associated with greater adherence to therapy and treatment (Flickinger, Saha, Moore, and Beach, 2013).
Substance use behaviors are linked with lower rates of engagement with care and medication adherence (Horvath, Carrico, Simoni,
Boyer, Amico, and Petroli, 2013). This study is a secondary data analysis using a cross-sectional design from a larger randomized
controlled trial (𝑛 = 775) that investigated the efficacy of a self-care symptom management manual for participants living with
HIV. Participants were recruited from countries of Africa and the US. This study provides evidence that substance use is linked
with lower self-reported engagement with care and adherence to therapy. Data on substance use and engagement are presented.
Clinical implications of the study address the importance of utilizing health care system and policy factors to improve engagement
with care.

1. Introduction
Engagement with care is a critical element of successful
adaptation to chronic illness, particularly in HIV disease [1].
Establishing a successful patient-provider relationship may
be linked with better outcomes for those living with HIV
including lower viral loads, fewer comorbid illnesses, and
slower progression to AIDS. Both alcohol and illicit drug
use are common among HIV-infected patients [2] and may
contribute to poorer adherence to antiretroviral therapy and
less engagement with health care providers. Substance use,
notably alcohol use, was found to predict HIV risk behavior
and sensation seeking in a sample of men and women in
South Africa [3] and contributes to lower utilization of
and adherence to antiretroviral therapy [4]. It is known
that medical providers have difficulty routinely addressing
unhealthy behaviors and substance use, and these behaviors
are not always addressed with patients in HIV treatment
settings [5]. Recently, Horvath et al. [6] found that stimulant
use was significantly correlated with missed HIV medical
appointments and that fewer stimulant-using men in the
study rated HIV medical care as a high priority.
1.1. Engagement with Care. Engagement with care is an
important element of the patient-provider relationship and
may be linked with health status outcomes, adherence to
therapy, and chronic and comorbid illness in HIV disease
[7]. A complex chronic illness such as HIV requires excellent
care, communication, and a committed partnership of patient
and provider [8, 9]. Dombrowski and colleagues [9] found
that engagement with care was the only significant factor
that was linked with both antiretroviral adherence and
viral load suppression. Bankoff and colleagues [10] noted
that positive patient-provider relationships were significantly
correlated with better physical health and functioning and
greater engagement in care. Rao et al. [11] noted that lack of
engagement in HIV care presents a major clinical challenge
in HIV care as well as a global public health challenge.
Mugavero et al. [12] examined health care system and
policy factors that influence engagement in HIV clinical care.
Their discussion included a socioecological framework that
includes salient health care system and policy factors that
influence engagement in HIV clinical care. They address
the importance of communication and “synergy between

funding and service agencies that provide HIV testing,
prevention, treatment, and supportive services” (p. S238).
Since HIV disease is a chronic and complex illness that
requires medication adherence, engagement with care, and
symptom management across the HIV trajectory, the impact
of, and the relationships among unhealthy substance use
behaviors, relationships with care providers and the presence
and severity of symptoms require exploration. Difficult symptoms are known to exist as a result of HIV disease and progression to AIDS, due to antiretroviral medication, and may
also be linked to comorbid unhealthy behaviors. It is known
that medical providers have difficulty routinely addressing
unhealthy behaviors and substance use, in particular, is often
not addressed with patients in HIV treatment settings [5].
1.2. Research Questions. The research questions were
Is there a relationship between engagement with
care, substance use behaviors, and adherence to
therapy in HIV disease? Are there differences in
adherence related to health care providers (nurse,
advanced practice nurse/nurse practitioner, or
physician) or by site?
1.3. Purpose of the Study. As part of a larger randomized
controlled study conducted by an international HIV/AIDS
network on self-care for symptoms in HIV disease, the
purpose of the present study was to examine the participants’
perception of engagement with care, self-reported substance
use, and adherence to therapy. The parent study was a randomized controlled trial of an HIV symptom management
manual and its effectiveness in addressing symptoms in HIV
disease. The prevalence of substance use behaviors including
excessive alcohol use, illicit drug use, and cigarette smoking
were examined as well as quality of life in HIV disease.
Although the larger study was a randomized controlled
trial of the use of a symptom management manual, the
present study reports on the descriptive, cross-sectional data
regarding engagement with care, adherence to therapy, and
substance use behaviors. SPSS PC version 16.0 was used to
analyze and categorize the study data. Quantitative methods
were used to analyze and summarize symptom data related to
unhealthy behaviors.
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2. Materials and Methods
This is a secondary analysis of data from a randomized
controlled trial to examine engagement with care, adherence,
and unhealthy self-care behaviors in a sample of persons
with HIV/AIDS. Data were collected in 14 sites in Africa
(Nairobi, Kenya, and Pretoria, South Africa), Puerto Rico,
and the United States (Boston, Chicago, Philadelphia, Salt
Lake City, San Diego, San Francisco, and Texas). The settings
included community-based organizations, university-based
AIDS clinics, private practices, public and for-profit hospitals,
residential and day care facilities, and home care services.
Institutional review board (IRB) approval was obtained at
each of the sites where data were collected as well as from the
UCSF International Nursing Research Network IRB.
2.1. Participants. The sample for this study included HIVinfected individuals (𝑛 = 775) from the U.S. (Boston,
9.0%, Chicago 2.1%, Philadelphia, 13.8%, California 13.8%,
Texas 24.5%, and Salt Lake City 9.0%), Pretoria, South Africa
(6.2%), and Nairobi, Kenya (9.2%). Of the larger sample
of 775 participants, a majority of the respondents reported
substance use behaviors. Inclusion criteria for the study were
that participants had to be (a) at least 18 years of age, (b)
receiving HIV-related care at their respective facilities, (c)
able to provide informed consent, and (d) able to complete
the questionnaire independently or with the assistance of a
research assistant.
2.2. Measures
2.2.1. Demographic Survey. A 13-item self-report survey was
utilized to collect demographic information and illness background data for the study. Questions addressed personal
and environmental characteristics including age, gender,
years of education, adequacy of income, and whether they
had children among other variables. In addition, data on
biological/physiological factors, such as whether participants
had received an AIDS diagnosis or had any comorbidities,
were also collected.
2.3. Engagement with Health Care Provider (HCP). The
health care provider engagement with care instrument (HCP)
is a 13-item scale where clients rate the nature of their
interactions with their health care providers on a fourpoint scale with 1 = always true and 4 = never true. A
low score indicates greater provider engagement. The scale
was submitted to a principal components factor analysis
with varimax rotation. A one-factor solution emerged with
an eigenvalue of 8.6 and explaining 66.5% of the variance.
Cronbach’s alpha reliability estimate was 0.96 [7].
2.4. Revised ACTG Reasons for Nonadherence to Medications
(ACTGrev). The ACTG revised is a self-report measure of
reasons for missing medications [13] that was revised through
a large randomized clinical control study on adherence.
In this study, clients were asked to respond to reasons
for missing medications using a 4-point Likert-type scale
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ranging from never to often, with a higher score denoting
lesser adherence to their current medication regime. Factor
analysis was performed on Chesney and colleagues’ [13]
original 14 item instrument, producing 2 factors with a total
of nine items: pill taking problems (5 items) and forgetfulness
(4 items). These nine items constitute the revised scale.
Each factor or subscale can be summed separately and then
collectively to create the total score. Cronbach’s alphas for the
2 subscales and the total score ranged from 0.80 to 0.90.
2.5. Drug and Alcohol Use Scale (DAS). This 35-item scale was
derived from the Addiction Severity Index (ASI), which is
the most widely used standardized instrument in assessing
substance use [14]. The ASI is a semistructured interview
containing 161 questions in seven categories that assess
demographic information, medical status, employment and
education, family and social background, psychiatric status,
history of drug and alcohol use, and legal status. Test retest
reliability coefficients of 0.83 over a 2-day period have been
demonstrated with the whole tool. The 35-item drug and
alcohol scale was transformed from a semistructured format
to a self-report questionnaire for use in this study. This scale
inquires about lifetime use patterns and drug use episodes
specifically in the past 30 days. Administration time for the
drug and alcohol scale has been estimated at about 5 minutes.
Level of substance use will be determined by the number of
times participants report using specific drugs in the past 30
days.
2.6. Data Analyses. Standard descriptive statistics were used
to describe the demographic characteristics, illness background, engagement with care, adherence to therapy, and
unhealthy behaviors for symptom management. The alpha
level for all statistics was set at 0.05 and SPSS (version 18.0)
was used for all data analyses. Means, standard deviations,
and 𝑡-tests for levels of engagement with care and unhealthy
behaviors were calculated. Significant differences between
engagement with care, adherence, and unhealthy behaviors
were examined.

3. Results
Demographic and illness background data are presented
in Table 1. The sample was composed of 59% (𝑛 = 455)
males, 38.5% (𝑛 = 296) females, and 2.2% (𝑛 = 17) who
self-identified as transgender. Ages ranged from 20 to 72
years (𝑀 = 42.8, SD 9.6 years). The largest racial groups
represented were African national and African American
(43.6%; 𝑛 = 335), Hispanic/Latino (27.8%; 𝑛 = 214), and
White/Anglo (21.2%; 𝑛 = 163). Most of the participants
had at least a high school education (70.9%; 𝑛 = 544)
although 78.2% (𝑛 = 604) indicated that their income was,
at best, barely adequate. Forty-two percent (𝑛 = 322) of
the participants had an AIDS diagnosis. The mean years of
known HIV-positive diagnosis was 9.1 years and the majority
of participants were currently taking antiretroviral medications (70.4%; 𝑛 = 537) and had been taking antiretroviral
medications for a mean number of 6.7 years. Their most
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Table 1: Sample demographics.

Gender
Male
Female
Transgender
Age
Race
Asian/Pacific Islander
African national and American/black
Hispanic/Latino
Native American Indian
White/Anglo (non-Hispanic)
Other
Highest education
Grade school
High school
Technical/vocational school
College
Master’s
Doctorate
# Children at home
0
1
2
3
>4
Data Collection Sites
USA (10)
California (3)
Texas (3)
Massachusetts (1)
Utah (1)
Illinois (1)
Pennsylvania (1)
Africa (2)
South Africa (1)
Kenya (1)
Puerto Rico (2)
San Juan (1)
Vega Baja (1)
AIDS diagnosis
Yes
No
Don’t know
Taking HIV Meds now
Yes
No
Other Medical Conditions
Yes
No
Years HIV Positive
Recent CD4 Count (if known)
Viral Load “Undetectable”
Viral Load (Greater than 50 copies/mL) (𝑛 = 146)
Years on ARV Medications

455
296
17
42.8 years

59.2%
38.5%
2.2%
SD = 9.6 (range 20–72)

11
335
214
8
163
37

1.4%
43.6%
27.8%
1.0%
21.2%
4.8%

223
318
143
59
20
4

29.1%
41.5%
18.6%
7.7%
2.6%
0.5%

139
81
80
31
36

37.9%
22.1%
21.8%
8.4%
9.8%

107
190
69
69
16
107

13.8%
24.5%
9.0%
9.0%
2.0%
13.8%

48
71

6.2%
9.2%

70
28

9.0%
3.6%

322
408
37

42.0%
53.2%
4.8%

537
226

70.4%
29.6%

470
280
9.1 years
407
251
50368
6.7 years

62.7%
37.3%
SD ± 6.6 (Range: 0–26)
SD ± 268 (Range: 0–1200)
33.4%
SD ± 135000 (Range: 50–750000)
SD ± 5.2 (Range: 0–20)
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Health care provider

HCP total (mean)

20

18.5

18.4

16
12
8
4
0

Doctor

20.6

16

16.8

20.3
17.4

16.7

Philadelphia

18

Puerto Rico

HCP total (mean)

20

Nurse/NP
Site

24

17.7

15.3

15.7

12
8

South Africa

Texas

Chicago

San Diego

Boston

Salt Lake

0

SF

4

HCP and site
24
20

18 18

16

20.7

20.7
16.8

17.5 17.2

21.5

20.3 20.4

19.2
15

16.8

16.1

15.3

15.3

12
8

Doctor
Nurse/NP

Doctor
Nurse/NP

Doctor
Nurse/NP

Doctor
Nurse/NP

Doctor
Nurse/NP

Doctor
Nurse/NP

Doctor
Nurse/NP

Doctor
Nurse/NP

Salt Lake

Boston

Puerto Rico

Philadelphia

San Diego

Chicago

Texas

South Africa

0

Doctor
Nurse/NP

4

SF

HCP total (mean)

recent CD4 counts ranged from 0 to 1200 with a mean CD4
count of 407; 62.7% (𝑛 = 470) reported that they had other
comorbid medical conditions in addition to HIV/AIDS.
Several symptoms were significantly associated with
unhealthy substance use behaviors. In particular, fatigue and
emotional stress were correlated with all four substance use
behaviors (heavy alcohol use, illicit drug use, marijuana, and
tobacco). Of note is that nearly half of the sample (45.8%; 𝑛 =
355) reported tobacco use and nearly 15% reported marijuana
use (𝑛 = 111, 14.3%). Illicit drug use was self-reported by
2.6% of the sample (𝑛 = 98) and heavy alcohol use by 8.5%
(𝑛 = 66).
Figure 1 displays the baseline engagement with care scores
by health care provider, site, and provider/site. Respondents
indicated that mean values on health care provider responses
were not significantly different for those whose care was
offered by physicians or those who had nurse providers
(physician care 𝑀 = 18.4; nurse care 𝑀 = 18.5). There were
also no significant differences in engagement with care by
site. It is of note that the engagement with care data was not
collected for this analysis in Kenya and thus analyses from
countries of Africa are limited. In some sites, respondents
indicated greater engagement with care when cared for by a
physician including. Participants in Boston and South Africa
had greater engagement with care reported by those who
received care from nurse; however, none of the engagement
with care scores were significantly different.
In Figure 2, baseline engagement with care and substance
use are displayed. The lowest scores of engagement with care
were for those who used hallucinogens (𝑀 = 23.6) followed
by cocaine users (𝑀 = 21.1). It is interesting to note that
for those who used heroin, the mean engagement with care
scores were low at 17.1. The lowest engagement with care
score was for those using barbiturate medications. However
none of the engagement with care scores were significantly
different based on self-report of specific illicit drugs used by
participants. The highest adherence scores and lowest reports
of substance use were in South Africa. Not surprisingly, mean
engagement with care scores were the highest in those who
did not report any drug use. Regarding adherence to therapy,
respondents in Puerto Rico had the poorest adherence to
therapy. For those who had a nurse provider, the highest mean
scores of adherence were in South Africa (0.111; 𝑛 = 9),
Philadelphia (5.35; 𝑛 = 17), and Boston (6.5; 𝑛 = 2). The
lowest mean scores of adherence were Puerto Rico (11.1; 𝑛 =
4), Texas (11.1; 𝑛 = 14), and San Diego (8.25; 𝑛 = 4).
It is of note that Wilcoxon 𝑡-tests indicated that symptom
burden was significantly higher for those who reported use
versus nonuse of alcohol (𝑃 < 0.001), tobacco (𝑃 < 0.001),
illicit drugs (𝑃 < 0.0001), and marijuana (𝑃 < 0.004).
Mean symptom burden for substance users for alcohol was
9.0, while nonusers reported a symptom burden of 6.6 (𝑃 <
0.001). For illicit drugs, mean symptom burden for users was
9.1, while nonusers reported a mean symptom burden score
of 6.5 (𝑃 < 0.0001). Marijuana users reported a symptom
burden of 8.3 and nonusers had a mean score of 6.5 (𝑃 <
0.004); tobacco users reported a mean symptom burden score
of 7.6 and nonusers had a score of 6.1 (𝑃 < 0.001).
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Figure 1: Baseline engagement with care (by health care Provider,
site, and provider/site). Engagement with care is scaled such that
lower scores denote better engagement.

4. Discussion
In this study, substance use was associated with significantly
lower scores of engagement with care and linked with
poorer adherence to therapy. These results are important
in addressing HIV care and providing support for patients
across the trajectory of HIV disease. Although the sample
was primarily male, the HIV epidemic increasingly affects
female populations—particularly in the participants in South
Africa. Symptoms that were most associated with unhealthy
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20
15

23.6

21.1
19.1
19.5
18.7 18.818.2 18.3 18.6
18.3 18.7
15.9

18.7
17.1

20.7 19.5
20
18.3 18.5 18.5

10

Sedatives No
Yes

Methadone No
Yes

Inhalants No
Yes

Heroin No
Yes

Hallucinogens No
Yes

Cocaine No
Yes

Cannabis No
Yes

Barbituates No
Yes

0

Amphetamines No
Yes

5
Alcohol No
Yes

Mean HCP total (HCPTOT)

Substance use within past 30 days
25

Figure 2: Baseline engagement with care vis-a-vis substance use
within the past 30 days. Engagement with care is scaled such that
lower scores denote better engagement.

for this population. In particular, HIV disease may have
occurred due to substance use and injection drugs. It is
important that assessment of ongoing substance use be a
key intervention at each visit with a provider. Evaluation of
educational interventions by providers should be conducted
at each HIV visit.
Future research should examine the HIV provider role
in assessment of substance use in those living with HIV
as well as substance use education. In addition, nurses and
physicians should actively engage in the comprehensive plan
of care as well as addressing the potential negative effects of
substance use for those with HIV/AIDS. As individuals live
longer with HIV disease as a chronic illness, other comorbid
conditions frequently arise (diabetes and heart disease) and
substance use may also add a complex dimension to their
care. Further research is likely to uncover additional interventions that could support improved care of those with active
and past substance users in leading healthy lifestyles with
HIV disease.
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substance use behaviors were fatigue and emotional stress.
Both were significantly correlated with all four substance use
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